Cipla signs exclusive licensing deal with SBP Group for HER2-targeted ADC EP News Bureau Sep 2, 2026 SBP Group subsidiary Chia Tai Tianqing Pharmaceutical Group (CTTQ) has granted Cipla exclusive rights to develop and commercialise…
